Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Medicinova Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −10 vs. Q4 2021
- Shares held
- 7.13M
- −494.3K (−6.5%) vs. Q4 2021
- Total value
- $19.0M
- −$1.39M (−6.8%) vs. Q4 2021
- New holders
- 2
- 9 more added
- Sold out
- 12
- 12 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,827,732 | $4.88M | 0.00% | −9,449−0.5% | Reduced |
| Essex Woodlands Management, Inc. | 1,105,941 | $2.95M | 0.71% | 00.0% | Unchanged |
| BlackRock Inc. | 721,854 | $1.93M | 0.00% | −10,038−1.4% | Reduced |
| Geode Capital Management, LLC | 451,510 | $1.21M | 0.00% | +844+0.2% | Added |
| Citigroup Inc | 447,957 | $1.20M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 377,792 | $1.01M | 0.00% | −13,427−3.4% | Reduced |
| JPMorgan Chase & Co | 308,276 | $823.0K | 0.00% | +7,110+2.4% | Added |
| Susquehanna International Group, LLP | 267,543 | $714.0K | 0.00% | −8,735−3.2% | Reduced |
| Bridgeway Capital Management, LLC | 205,147 | $548.0K | 0.01% | −15,000−6.8% | Reduced |
| UBS Group AG | 189,940 | $506.0K | 0.00% | +738+0.4% | Added |
| Barclays PLC | 184,600 | $493.0K | 0.00% | +11,800+6.8% | Added |
| Bank of America Corp | 179,477 | $480.0K | 0.00% | −32,081−15.2% | Reduced |
| Northern Trust Corp | 160,975 | $430.0K | 0.00% | −1,823−1.1% | Reduced |
| Renaissance Technologies LLC | 149,700 | $400.0K | 0.00% | +7,400+5.2% | Added |
| State Street Corp | 142,298 | $380.0K | 0.00% | +9,449+7.1% | Added |
| Bank of New York Mellon Corp | 121,045 | $323.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 50,574 | $135.0K | 0.00% | −4,281−7.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 50,400 | $135.0K | 0.00% | +5,800+13.0% | Added |
| Price T Rowe Associates Inc | 43,100 | $115.0K | 0.00% | +11,600+36.8% | Added |
| Bailard, Inc. | 28,222 | $75.0K | 0.00% | +28,222 | New |
| Ameriprise Financial Inc | 27,200 | $73.0K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 19,000 | $51.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 17,843 | $48.0K | 0.00% | 00.0% | Unchanged |
| Blankinship & Foster, LLC | 15,700 | $42.0K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 15,380 | $41.0K | 0.00% | −6,061−28.3% | Reduced |
| WealthTrust Axiom LLC | 12,500 | $33.0K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,494 | $12.0K | 0.00% | +4,231+1,608.7% | Added |
| Cutler Group LP | 2,000 | $5.00K | 0.00% | −100−4.8% | Reduced |
| BNP Paribas Arbitrage, SA | 584 | $1.56K | 0.00% | −766−56.7% | Reduced |
| Wells Fargo & Company | 302 | $1.00K | 0.00% | −18−5.6% | Reduced |
| Northwestern Mutual Wealth Management Co | 305 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 195 | $0 | 0.00% | +195 | New |
| Anson Funds Management LP | 0 | $0 | 0.00% | −131,495−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −110,200−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −53,700−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −42,945−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −33,516−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −29,542−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,160−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,988−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,797−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,460−100.0% | Sold out |
| Buckingham Strategic Partners | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |